Kathleen Valiasek

An entrepreneurial executive, Kathleen offers a 30 year record of driving profitable growth in public and privately held companies from start-ups to Fortune 500 companies, within the biotech, retail, telecommunications, real estate and healthcare markets.

Most recently, Kathleen served as CFO and CBO of Amyris, Inc., a publicly traded biotech and commercial stage manufacturing company with global operations. She closely partnered with the CEO to expand product offerings in B2B and consumer markets. Kathleen raised over $1B in debt and equity financing while simultaneously reducing debt and attracting institutional investors. As CBO, Kathleen led the strategic market entry into the pharmaceutical industry. During her tenure Amyris’ market cap grew from $300M to $5B.

Prior to Amyris, Kathleen provided strategic and financial consulting services through Lenox Group, Inc., the company she founded in 1996. Clients included Fortune 500 companies such as Albertsons, CVS, Gap, Kaiser Permanente and Softbank, as well as smaller clients preparing for IPOs. She was typically engaged for critical roles on multi-year assignments including M&A transactions, debt and equity financings, IPOs and spin-offs.

Kathleen earned a Bachelor of Business Administration – Accounting from the University of Massachusetts, Amherst.